[HTML][HTML] Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients

A Provenzani, A Santeusanio, E Mathis… - World Journal of …, 2013 - ncbi.nlm.nih.gov
The introduction of tacrolimus in clinical practice has improved patient survival after organ
transplant. However, despite the long use of tacrolimus in clinical practice, the best way to …

Recent advances in cyclosporine drug delivery: Challenges and opportunities

D Patel, S Wairkar - Drug Delivery and Translational Research, 2019 - Springer
Cyclosporine has been established as a gold standard for its immunosuppressant action.
Apart from this, the molecule is boon in treating broad spectrum of diseases like rheumatoid …

Assessment of the implementation of pharmacogenomic testing in a pediatric tertiary care setting

I Cohn, R Manshaei, E Liston, JBA Okello… - JAMA network …, 2021 - jamanetwork.com
Importance Pharmacogenomic (PGx) testing provides preemptive pharmacotherapeutic
guidance regarding the lack of therapeutic benefit or adverse drug reactions of PGx targeted …

[HTML][HTML] Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation

A Baroja-Mazo, B Revilla-Nuin, P Ramírez… - World journal of …, 2016 - ncbi.nlm.nih.gov
Mammalian target of rapamycin, also known as mechanistic target of rapamycin (mTOR) is a
protein kinase that belongs to the PI3K/AKT/mTOR signaling pathway, which is involved in …

Cascadion™ SM clinical analyzer: evaluation of the whole blood immunosuppressants quantification and routine usability

E Mathieu, C Duterme, D Fage, F Cotton - Clinica Chimica Acta, 2023 - Elsevier
Background Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS)
tends to overcome other methods for therapeutic drugs monitoring (TDM) due to its very …

Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients

FDV Genvigir, PC Salgado, CR Felipe… - Pharmacogenetics …, 2016 - journals.lww.com
Background Polymorphisms in genes encoding transport proteins and metabolizing
enzymes involved in tacrolimus (TAC) disposition may be important sources of individual …

Association of high intra-patient variability in tacrolimus exposure with calcineurin inhibitor nephrotoxicity in kidney transplantation

H Kim, A Han, S Ahn, SK Min, J Ha, S Min - Scientific Reports, 2023 - nature.com
Tacrolimus intra-patient variability (IPV) is a novel predictive marker for long-term kidney
transplantation outcomes. We examined the association between IPV and calcineurin …

Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC–MS/MS

M Ghareeb, F Akhlaghi - Bioanalysis, 2015 - Taylor & Francis
Immunosuppressive drugs used in solid organ transplants typically have narrow therapeutic
windows and high intra-and intersubject variability. To ensure satisfactory exposure …

Self-reported sleep disturbances in renal transplant recipients

H Burkhalter, DP Brunner, A Wirz-Justice, C Cajochen… - BMC nephrology, 2013 - Springer
Background Poor sleep quality (SQ) and daytime sleepiness (DS) are common in renal
transplant (RTx) recipients; however, related data are rare. This study describes the …

[HTML][HTML] Immunosuppressive serum levels in allogeneic hematopoietic stem cell transplantation: pharmaceutical care contribution

PM Corrêa, J Zuckermann, GB Fischer… - Pharmacy Practice …, 2016 - SciELO Espana
Background: Cyclosporine and tacrolimus are limited by a narrow therapeutic window.
Maintaining immunosuppressive drugs at desired levels may be difficult. Pharmaceutical …